跳至主要内容
临床试验/ACTRN12609000850279
ACTRN12609000850279尚未招募3 期

In adults with Chronic Obstructive Pulmonary Disease (COPD), is corticosteroid combined with long-acting beta-agonist effective in forced expiratory volume in one second (FEV1) values, as compared to corticosteroid?

Aché Laboratories0 个研究点目标入组 136 人开始时间: 2009年10月1日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
136

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
40 Years 至 o limit(—)
性别
All

入选标准

  • moderate or severe COPD according to GOLD (Global Initiative for Chronic Obstructive Lung Disease)
  • smoker or former smoker

排除标准

  • Hospitalization due to COPD up to 4 weeks before screening visit
  • Subjects who have required treatment with oral corticosteroids, anti-leukotriene, immunoglobulins, beta-blockers, digitalis, itraconazole 2 months prior to Visit 1

研究者

发起方
Aché Laboratories

相似试验